Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘nature publishing group’ Category

Shigeaki Kato up to 33 retractions, with five papers cited a total of 450 times

with 15 comments

Shigeaki Kato

Shigeaki Kato

Former University of Tokyo researcher Shigeaki Kato continues to put big numbers on the board.

Last month, we reported on his 26th, 27th, and 28th retractions, all in Nature Cell Biology and cited close to 700 times. Yesterday, EMBO Journal and EMBO Reports published a total of five more retractions for the endocrinology researcher, who resigned from the university in 2012 following investigations found he had faked images.

Here’s the notice for “A cell cycle-dependent co-repressor mediates photoreceptor cell-specific nuclear receptor function:” Read the rest of this entry »

Nature issues Expression of Concern for paper by author who threatened to sue Retraction Watch

with 69 comments

Ariel Fernandez, via Wikipedia

Ariel Fernandez, via Wikipedia

Nature has issued an Expression of Concern for a paper co-authored by a scientist who threatened to sue us last year for writing about another Expression of Concern for one of his other papers.

Here’s the “Editorial Expression of Concern” for “Non-adaptive origins of interactome complexity:”

Read the rest of this entry »

Updated: Former Vanderbilt scientist faked nearly 70 images, will retract 6 papers: ORI

with 23 comments

ori logoA former Vanderbilt University biomedical engineer committed fraud on a massive scale, according to a new Office of Research Integrity (ORI) report.

Igor Dzhura is banned from receiving federal funding for three years, and is retracting six papers, which have been cited more than 500 times. Since leaving Vanderbilt, he has worked at SUNY Upstate Medical University, and now works at Novartis.

According to the ORI, Dzhura was a busy boy at Vanderbilt, faking images and drastically inflating the number of experiments he conducted by duplicating computer files and saving them in nested folders. The total body count from his work includes: Read the rest of this entry »

Kidney journal to retract stem cell paper for duplicated and doctored images

with 2 comments

kidney intKidney International is in the process of retracting a stem cell paper containing plagiarized images, Retraction Watch has learned.

Here’s the notice that will appear for “Human renal stem/progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle-shuttled decorin“: Read the rest of this entry »

Shigeaki Kato up to 28 retractions, with three papers cited nearly 700 times

with 28 comments

Shigeaki Kato

Shigeaki Kato

Former University of Tokyo researcher Shigeaki Kato has notched his 26th, 27th, and 28th retractions, all in Nature Cell Biology. The three papers have been cited a total of 677 times.

Here’s the notice for “DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs:” Read the rest of this entry »

Written by Ivan Oransky

November 3rd, 2014 at 11:30 am

Fudged figures sink breast cancer paper

with 22 comments

oncogeneA prestigious cancer journal has pulled an article over “concerns” regarding some of the figures, which PubPeer commenters had tagged as suspect.

A few weeks after the paper was published on June 9, comments on PubPeer began accumulating. Commenters called out both potentially manipulated and repeated images. The exact timeline is not clear, because Oncogene does not list a date on the retraction notice, but by August 29 the paper had been retracted.

Here’s the notice for “IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer,” by researchers at Shanghai Jiaotong University School of Medicine and Ruijin Hospital, both in Shanghai, China, and the University of Michigan: Read the rest of this entry »

First author blamed for retraction in prestigious medical journal

with 41 comments

jemcoverThe authors of a Journal of Experimental Medicine have retracted it, blaming the first author for data and figure manipulation.

The paper, “The requirements for natural Th17 cell development are distinct from those of conventional Th17 cells,” was initially published in September 2011 and has been cited 25 times, according to Thomson Scientific’s Web of Knowledge. First author Jiyeon Kim was an MD-PhD candidate at the University of Pennsylvania until this year, according to a LinkedIn profile.

Here’s the notice: Read the rest of this entry »

Another Nature stem cell paper is retracted

with 8 comments

nature 73014Another stem cell paper has been retracted from Nature, this one a highly cited 2008 study that had already been the subject of what the journal’s news section called a “furore” in 2010.

According to that 2010 news story:

The researchers behind the original work1, led by Thomas Skutella of the University of Tübingen, reported using cells from adult human testes to create pluripotent stem cells with similar properties to embryonic stem cells.

But a 2010 Brief Communication Arising called those findings into question. And now, the authors have retracted the paper. Here’s the notice for “Generation of pluripotent stem cells from adult human testis:” Read the rest of this entry »

Incorrect analysis leads to Nature’s sixth retraction in 2014

with 5 comments

nature 714In what seems to be an example of researchers swiftly and transparently correcting the literature, and acknowledging errors, a pair of scientists have retracted a 2013 paper from Nature.

Here’s the retraction notice for “Genomic organization of human transcription initiation complexes,” by Bryan Venters and Frank Pugh: Read the rest of this entry »

Second Nature paper by researcher found to have violated academic integrity retracted

with 12 comments

dhonukshe

Pankaj Dhonukshe

A second Nature paper co-authored by Pankaj Dhonukshe, formerly of Utrecht University and VIB Ghent, has been retracted.

Here’s the notice for “Generation of cell polarity in plants links endocytosis, auxin distribution and cell fate decisions:” Read the rest of this entry »